Struthers Richard Scott
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) · President & CEO
Struthers Richard Scott is listed in filings as President & CEO at Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX). This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity. Recent filings connect the profile to Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX). The current snapshot covers public activity from Dec 4, 2024 to Jun 2, 2026. Reported amounts are shown as $489.7K to $10.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $180k4k shares | SellSep 26, 2025 | $45.00 | $83.90 | |
| $563k16.5k shares | SellMar 19, 2025 | $34.17 | $83.90 | |
| $30k875 shares | SellMar 19, 2025 | $34.83 | $83.90 | |
| $576k10k shares | SellDec 2, 2024 | $57.57 | $83.90 |